1. Home
  2. PRDO vs KOD Comparison

PRDO vs KOD Comparison

Compare PRDO & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perdoceo Education Corporation

PRDO

Perdoceo Education Corporation

HOLD

Current Price

$32.26

Market Cap

2.1B

Sector

Real Estate

ML Signal

HOLD

Logo Kodiak Sciences Inc

KOD

Kodiak Sciences Inc

HOLD

Current Price

$38.76

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRDO
KOD
Founded
1994
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.3B
IPO Year
1997
2018

Fundamental Metrics

Financial Performance
Metric
PRDO
KOD
Price
$32.26
$38.76
Analyst Decision
Buy
Buy
Analyst Count
1
7
Target Price
$42.00
$35.43
AVG Volume (30 Days)
610.6K
826.1K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
1.75%
N/A
EPS Growth
10.50
N/A
EPS
0.85
N/A
Revenue
$581,296,000.00
N/A
Revenue This Year
$4.28
N/A
Revenue Next Year
$2.89
N/A
P/E Ratio
$37.87
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.66
$3.72
52 Week High
$38.50
$47.84

Technical Indicators

Market Signals
Indicator
PRDO
KOD
Relative Strength Index (RSI) 42.01 58.86
Support Level $31.37 $32.93
Resistance Level $32.79 $46.72
Average True Range (ATR) 1.03 2.77
MACD -0.04 0.66
Stochastic Oscillator 23.51 92.72

Price Performance

Historical Comparison
PRDO
KOD

About PRDO Perdoceo Education Corporation

Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the its revenue comes from the Colorado Technical University segment.

About KOD Kodiak Sciences Inc

Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's proprietary ABC platform. Another investigational medicine, KSI-501, is an anti-interleukin 6, or IL-6, VEGF-trap bispecific therapy built on the ABC platform and is being developed for high-prevalence retinal vascular diseases and intended to address the unmet needs of extended durability and targeting disease biology beyond VEGF for differentiated efficacy. Its third investigational medicine, KSI-101, is a high-strength (100 mg/mL) bispecific protein targeting IL-6 and VEGF.

Share on Social Networks: